Taro Pharmaceutical Industries Ltd (NYSE:TARO)

Delayed Data
As of Sep 17
 -1.13 / -1.71%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Taro Pharmaceutical Industries Ltd have a median target of 82.00, with a high estimate of 82.00 and a low estimate of 82.00. The median estimate represents a +26.48% increase from the last price of 64.83.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Taro Pharmaceutical Industries Ltd. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 304.00%
Growthannually 125.89%


Growthquarterly 4.16%
Growthannually 12.34%
Key to the earnings and sales forecast charts.